Results 101 to 110 of about 125,156 (180)

Incidental Thyroid Neuroendocrine Carcinoma Revealing a Presumed Occult Gastrointestinal Malignancy. [PDF]

Cureus
Walker RJ, Aly FZ, Gorris M, Slijepcevic A, Sullivan CA.   +4 more
europepmc   +1 more source

Prognostic Factors in Medullary Thyroid Cancer: A Real-World Study in a Referral Center. [PDF]

Biomedicines
Lauretta R, Puliani G, Terrenato I, Bianchini M, Mormando M, Appetecchia M.   +5 more
europepmc   +1 more source

Calcified liver metastases from medullary thyroid carcinoma in a Multiple Endocrine Neoplasia Type 2A patient. [PDF]

Radiol Case Rep
Tang CL, Ng FH.
europepmc   +1 more source

GLP-1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications. [PDF]

J Intern Med
Ueda P.
europepmc   +1 more source

Application of theranostics in thyroid cancer management.

J Clin Endocrinol Metab
Sridhar A, Behiri N, Klubo-Gwiezdzinska J.   +2 more
europepmc   +1 more source

Targeted therapies in the management of advanced medullary thyroid cancer. [PDF]

Oncologist
Arain HA, Izhar A, Caretti R, Chen H, Vodopivec DM.   +4 more
europepmc   +1 more source

Renal Medullary Carcinoma: Utility of [¹⁸F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management. [PDF]

J Nucl Med
Krebs S, Salem AE, Nguyen NC, Sheth RA, Karam JA, Daw NC, Tang C, Tannir NM, Msaouel P, Surasi DS.   +9 more
europepmc   +1 more source

Treatments for Medullary Thyroid Cancer Compared to Metastatic Medullary Thyroid Cancer

openaire   +1 more source